Adefovir Dipivoxil Kit



Indications and Reactions:

Role Indications Reactions
Primary
Hepatitis B 69.4%
Diabetes Mellitus 6.1%
Product Used For Unknown Indication 4.1%
Dyslipidaemia 3.1%
Hepatic Neoplasm Malignant 3.1%
Neoplasm Malignant 3.1%
Hepatic Cirrhosis 2.0%
Lung Infection 2.0%
Pyrexia 2.0%
Antiviral Prophylaxis 1.0%
Arthralgia 1.0%
Diarrhoea 1.0%
Hepatitis 1.0%
Pain 1.0%
Thrombocytopenia 12.8%
Osteomalacia 10.3%
Aspartate Aminotransferase Increased 7.7%
Blood Albumin Decreased 7.7%
Renal Injury 7.7%
Alanine Aminotransferase Increased 5.1%
Ascites 5.1%
Hepatic Failure 5.1%
Hypophosphataemia 5.1%
Proteinuria 5.1%
Transaminases Increased 5.1%
Acute Hepatic Failure 2.6%
Blood Bilirubin Increased 2.6%
Blood Creatine Phosphokinase Increased 2.6%
Blood Creatinine Increased 2.6%
Diabetic Nephropathy 2.6%
Drug Ineffective 2.6%
Encephalopathy 2.6%
Genotype Drug Resistance Test Positive 2.6%
Hepatic Function Abnormal 2.6%
Secondary
Hepatitis B 28.6%
Hiv Infection 22.4%
Antiretroviral Therapy 18.0%
Chronic Hepatitis 3.7%
Thyroid Cancer 3.3%
Diabetes Mellitus 2.9%
Chronic Lymphocytic Leukaemia 2.4%
Drug Use For Unknown Indication 2.4%
Lymphoma 2.4%
Hepatic Cirrhosis 2.0%
Splenic Marginal Zone Lymphoma 2.0%
Diffuse Large B-cell Lymphoma 1.6%
Idiopathic Thrombocytopenic Purpura 1.6%
Acute Myeloid Leukaemia 1.2%
Hepatic Neoplasm Malignant 1.2%
Neoplasm Malignant 1.2%
Hepatitis 0.8%
Hepatitis B Virus 0.8%
Product Used For Unknown Indication 0.8%
Autoimmune Hepatitis 0.4%
Renal Injury 13.4%
Viral Infection 13.4%
Hepatitis B 11.9%
No Therapeutic Response 6.0%
Weight Decreased 6.0%
Aspartate Aminotransferase Increased 4.5%
Peripheral Sensory Neuropathy 4.5%
Squamous Cell Carcinoma 4.5%
Acute Hepatic Failure 3.0%
Alanine Aminotransferase Increased 3.0%
Drug Exposure During Pregnancy 3.0%
Hepatic Failure 3.0%
Lactic Acidosis 3.0%
Myalgia 3.0%
Myelitis Transverse 3.0%
Obesity 3.0%
Pancreatitis Acute 3.0%
Renal Failure 3.0%
Trisomy 13 3.0%
Vomiting 3.0%
Concomitant
Hepatitis B 29.0%
Hepatic Neoplasm Malignant 9.0%
Hiv Infection 8.4%
Drug Use For Unknown Indication 7.2%
Product Used For Unknown Indication 6.0%
Prophylaxis 5.4%
Nutritional Support 4.8%
B-cell Lymphoma 4.5%
Supplementation Therapy 3.3%
Decreased Appetite 2.7%
Ascites 2.4%
Hepatic Cirrhosis 2.4%
Hypertension 2.4%
Organ Transplant 2.4%
Diarrhoea 2.1%
Anaemia 1.8%
Hepatitis B Virus 1.8%
Liver Disorder 1.8%
Oedema Peripheral 1.5%
Abdominal Pain 1.2%
Hbv Dna Increased 10.1%
Vomiting 10.1%
Nausea 5.8%
Oedema Peripheral 5.8%
Pain In Extremity 5.8%
Renal Impairment 5.8%
Tachycardia 5.8%
Therapeutic Response Decreased 5.8%
Viral Mutation Identified 5.8%
White Blood Cell Count Increased 5.8%
Hepatitis B 4.3%
Transaminases Increased 4.3%
Wound 4.3%
Central Nervous System Lymphoma 2.9%
Drug Interaction 2.9%
Gastroenteritis Radiation 2.9%
Hemianopia 2.9%
Hepatic Encephalopathy 2.9%
Hepatic Neoplasm Malignant 2.9%
Hepatitis B Dna Increased 2.9%
Interacting
Immunosuppression 100.0%
Hypophosphataemia 100.0%